It was within the discretion of the trial court to deny leave to amend a complaint because the proposed amendment, like the complaint it was intended to cure, failed to specifically identify the…
Substantial evidence supported a Patent Trial and Appeal Board (PTAB) decision finding the challenged claims were obvious.
A PTAB decision finding that Sony Interactive Entertainment had shown that a…
There was no error in an inter partes review decision finding obviousness in a communication system patent because the board properly relied on materials in the record in its claim construction and…
The combination of two well-known high blood pressure medicines did not result in unexpected patient benefits.
The U.S. Court of Appeals for the Federal Circuit has upheld a decision by the Patent…
The Patent Trial and Appeal Board (PTAB) did not err by declining to consider a patentee’s claim construction arguments raised for the first time at oral argument.
The holder of a patent for retail…
Because prior art described a method that could execute an application on one computer server, it should have been obvious that the method could be applied to multiple servers.
The Patent Trial and…
The claimed methods of filtering, highlighting, and selecting portions of maps or other visual information for display had long been done by hand, and the claims failed to describe specific…
The U.S. Federal Rules of Civil Procedure allow parties to obtain discovery regarding any matter that is relevant to a party’s claim or defense. One important caveat to this general principle is that…
Expanding on its 2016 Cuozzo decision, the U.S. Supreme Court holds that the "no appeal" provision of 35 U.S.C. § 314(d) precludes judicial review of the agency’s application of Section 315(b)’s time…
Because the patent failed to disclose the absence of a loading dose, the no-loading-dose limitation was without adequate written description support.
A divided Federal Circuit panel has reconsidered…
